• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

REST失活以及ASCL1和POU3F4的共表达是RB1/TP53失活的肺腺癌完全转化为神经内分泌癌所必需的。

REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.

作者信息

Masawa Meitetsu, Sato-Yazawa Hanako, Kashiwagi Korehito, Ishii Jun, Miyata-Hiramatsu Chie, Iwamoto Masami, Kohno Kakeru, Miyazawa Tadasuke, Onozaki Masato, Noda Shuhei, Shimizu Yasuo, Niho Seiji, Yazawa Takuya

机构信息

Department of Respiratory Medicine, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Japan.

Department of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Japan.

出版信息

Am J Pathol. 2022 Jun;192(6):847-861. doi: 10.1016/j.ajpath.2022.03.007. Epub 2022 Mar 30.

DOI:10.1016/j.ajpath.2022.03.007
PMID:35367201
Abstract

Although recent reports have revealed the importance of the inactivation of both RB1 and TP53 in the transformation from lung adenocarcinoma into neuroendocrine carcinoma (NEC), the requirements for complete transformation into NEC have not been elucidated. To investigate alterations in the characteristics associated with the inactivation of RB1/TP53 and define the requirements for transformation into NEC cells, RB1/TP53 double-knockout A549 lung adenocarcinoma cells were established, and additional knockout of REST and transfection of ASCL1 and POU class 3 homeobox transcription factors (TFs) was conducted. More than 60 genes that are abundantly expressed in neural cells and several genes associated with epithelial-to-mesenchymal transition were up-regulated in RB1/TP53 double-knockout A549 cells. Although the expression of chromogranin A and synaptophysin was induced by additional knockout of REST (which mimics the status of most NECs), the expression of another neuroendocrine marker, CD56, and proneural TFs was not induced. However, coexpression of ASCL1 and POU3F4 in RB1/TP53/REST triple-knockout A549 cells induced the expression of not only CD56 but also other proneural TFs (NEUROD1 and insulinoma-associated 1) and induced NEC-like morphology. These findings suggest that the inactivation of RB1 and TP53 induces a state necessary for the transformation of lung adenocarcinoma into NEC and that further inactivation of REST and coexpression of ASCL1 and POU3F4 are the triggers for complete transformation into NEC.

摘要

尽管最近的报告揭示了RB1和TP53失活在肺腺癌向神经内分泌癌(NEC)转变中的重要性,但完全转变为NEC的必要条件尚未阐明。为了研究与RB1/TP53失活相关的特征变化,并确定向NEC细胞转变的必要条件,我们建立了RB1/TP53双敲除A549肺腺癌细胞,并进行了REST的额外敲除以及ASCL1和POU3类同源框转录因子(TFs)的转染。在RB1/TP53双敲除A549细胞中,60多个在神经细胞中大量表达的基因以及几个与上皮-间质转化相关的基因上调。尽管通过额外敲除REST(模拟大多数NEC的状态)诱导了嗜铬粒蛋白A和突触素的表达,但另一种神经内分泌标志物CD56和神经源性TFs的表达并未被诱导。然而,在RB1/TP53/REST三敲除A549细胞中共表达ASCL1和POU3F4不仅诱导了CD56的表达,还诱导了其他神经源性TFs(NEUROD1和胰岛素瘤相关蛋白1)的表达,并诱导了NEC样形态。这些发现表明,RB1和TP53的失活诱导了肺腺癌向NEC转变所需的状态,而REST的进一步失活以及ASCL1和POU3F4的共表达是完全转变为NEC的触发因素。

相似文献

1
REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.REST失活以及ASCL1和POU3F4的共表达是RB1/TP53失活的肺腺癌完全转化为神经内分泌癌所必需的。
Am J Pathol. 2022 Jun;192(6):847-861. doi: 10.1016/j.ajpath.2022.03.007. Epub 2022 Mar 30.
2
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.NOTCH、ASCL1、p53和RB基因改变定义了一条驱动神经内分泌和小细胞肺癌的替代途径。
Int J Cancer. 2016 Feb 15;138(4):927-38. doi: 10.1002/ijc.29835. Epub 2015 Sep 25.
3
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.同时存在 RB1 和 TP53 改变的 EGFR 突变型肺癌具有组织学转化和临床结局不良的风险。
J Thorac Oncol. 2019 Oct;14(10):1784-1793. doi: 10.1016/j.jtho.2019.06.002. Epub 2019 Jun 19.
4
Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.achaete-scute complex homologue 1 (ASCL1) 在肺神经内分泌癌中的意义;使用小细胞肺癌细胞和 Ascl1 诱导的肺神经内分泌癌细胞进行 RNA 序列分析。
Histochem Cell Biol. 2020 Jun;153(6):443-456. doi: 10.1007/s00418-020-01863-z. Epub 2020 Mar 13.
5
Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.在小细胞肺癌细胞中表达的III/IV类POU转录因子参与神经源性/神经内分泌分化。
Pathol Int. 2014 Sep;64(9):415-22. doi: 10.1111/pin.12198.
6
Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.肺神经内分泌癌组织发生学研究的最新进展:从原始神经/神经内分泌细胞特异性转录因子功能分析中获得的证据
Pathol Int. 2015 Jun;65(6):277-85. doi: 10.1111/pin.12267. Epub 2015 Feb 24.
7
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.联合型小细胞肺癌与非小细胞肺癌不同组织学成分的临床病理与基因组学比较。
Lung Cancer. 2018 Nov;125:282-290. doi: 10.1016/j.lungcan.2018.10.006. Epub 2018 Oct 9.
8
Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.Ascl1 诱导的 Wnt11 调节小细胞肺癌的神经内分泌分化、细胞增殖和 E-钙黏蛋白表达,Wnt11 调节小细胞肺癌生物学。
Lab Invest. 2019 Nov;99(11):1622-1635. doi: 10.1038/s41374-019-0277-y. Epub 2019 Jun 23.
9
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications.神经调节蛋白 1(NEUROD1)、激活素 A 受体样激酶 1(ASCL1)和 POU 类 2 型 3(POU2F3)的差异表达定义了具有预后意义的膀胱小细胞/神经内分泌癌的分子亚型。
Mod Pathol. 2024 Oct;37(10):100557. doi: 10.1016/j.modpat.2024.100557. Epub 2024 Jul 2.
10
Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer.非小细胞肺癌中转化为小细胞肺癌与 EGFR 无关,并且由 SMAD4 介导的 ASCL1 转录独立于 RB1 而加速。
Cell Commun Signal. 2024 Jan 17;22(1):45. doi: 10.1186/s12964-023-01260-8.

引用本文的文献

1
Histologic transformation after targeted therapy resistance in driver gene-positive NSCLC: mechanisms and therapeutic challenges.驱动基因阳性非小细胞肺癌靶向治疗耐药后的组织学转化:机制与治疗挑战
Ther Adv Med Oncol. 2025 Sep 1;17:17588359251369038. doi: 10.1177/17588359251369038. eCollection 2025.
2
High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader.神经内分泌癌中高表达的 Cereblon 使细胞对 GSPT1 分子胶降解剂敏感。
Exp Hematol Oncol. 2025 Jun 23;14(1):89. doi: 10.1186/s40164-025-00674-z.
3
A novel transient receptor potential C3/C6 selective activator induces the cellular uptake of antisense oligonucleotides.
一种新型瞬时受体电位 C3/C6 选择性激动剂可诱导反义寡核苷酸的细胞摄取。
Nucleic Acids Res. 2024 May 22;52(9):4784-4798. doi: 10.1093/nar/gkae245.
4
Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy.免疫治疗后 NSCLC 发生组织学转化为小细胞肺癌:一种重要的耐药机制。
Front Immunol. 2023 Oct 30;14:1275957. doi: 10.3389/fimmu.2023.1275957. eCollection 2023.
5
Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study.依托泊苷/铂类联合安罗替尼治疗EGFR-TKI耐药后由EGFR突变型肺腺癌转化而来的小细胞肺癌患者:一项回顾性观察研究
Front Oncol. 2023 Jun 9;13:1153131. doi: 10.3389/fonc.2023.1153131. eCollection 2023.